|
DDX31 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.024300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.848190E-01 |
| Normal-vs-Stage2 |
2.536000E-01 |
| Normal-vs-Stage3 |
1.600010E-04 |
| Normal-vs-Stage4 |
4.620100E-04 |
| Stage1-vs-Stage2 |
6.682000E-01 |
| Stage1-vs-Stage3 |
1.220570E-03 |
| Stage1-vs-Stage4 |
2.317800E-03 |
| Stage2-vs-Stage3 |
9.684100E-02 |
| Stage2-vs-Stage4 |
9.515900E-02 |
| Stage3-vs-Stage4 |
8.575200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.815700E-04 |
| Normal-vs-AfricanAmerican |
7.050800E-01 |
| Normal-vs-Asian |
7.314300E-02 |
| Caucasian-vs-AfricanAmerican |
3.203200E-03 |
| Caucasian-vs-Asian |
2.871500E-02 |
| AfricanAmerican-vs-Asian |
1.393700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.46939999999963E-05 |
| Normal-vs-Female |
5.268200E-01 |
| Male-vs-Female |
3.558900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.740700E-03 |
| Normal-vs-Age(41-60Yrs) |
7.576000E-02 |
| Normal-vs-Age(61-80Yrs) |
5.622400E-04 |
| Normal-vs-Age(81-100Yrs) |
4.465400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.509800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.383800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.065400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.718400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.731800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.575800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.411200E-01 |
| Normal-vs-Grade 2 |
3.284400E-01 |
| Normal-vs-Grade 3 |
1.239160E-03 |
| Normal-vs-Grade 4 |
4.2008999999732E-06 |
| Grade 1-vs-Grade 2 |
7.524400E-01 |
| Grade 1-vs-Grade 3 |
2.165400E-01 |
| Grade 1-vs-Grade 4 |
2.843700E-02 |
| Grade 2-vs-Grade 3 |
1.086460E-02 |
| Grade 2-vs-Grade 4 |
6.09109999999413E-05 |
| Grade 3-vs-Grade 4 |
2.450100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.501800E-01 |
| Normal-vs-ccB subtype |
2.03129999999385E-05 |
| ccA subtype-vs-ccB subtype |
3.91120000000633E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.878800E-03 |
| Normal-vs-N1 |
5.706600E-01 |
| N0-vs-N1 |
6.178800E-01 |
|
|
